BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 4986889)

  • 1. The antigens of Vibrio cholerae involved in the vibriocidal action of antibody and complement.
    Neoh SH; Rowley D
    J Infect Dis; 1970 May; 121(5):505-13. PubMed ID: 4986889
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative assay of a protein antigen of vibrio cholerae involved in the vibriocidal action of antibody and complement.
    Neoh SH; Rowley D
    Aust J Exp Biol Med Sci; 1971 Dec; 49(6):605-12. PubMed ID: 5170447
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunity to cholera: relation of fraction II of type 2 cholera toxin to vibriocidal antibody.
    Kaur J; Burrows W
    J Bacteriol; 1969 May; 98(2):467-74. PubMed ID: 4977478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM
    Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guinea pig complement potently measures vibriocidal activity of human antibodies in response to cholera vaccines.
    Kim KW; Jeong S; Ahn KB; Yang JS; Yun CH; Han SH
    J Microbiol; 2017 Dec; 55(12):973-978. PubMed ID: 29214494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical studies of oral fusobacteria. 5. Serological characterization of a group reactive antigen.
    Kristoffersen T
    Acta Pathol Microbiol Scand; 1969; 77(4):707-16. PubMed ID: 4986614
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunochemical studies on lipopolysaccharide from agglutinable and non-agglutinable vibrios.
    Guhathakurta B; Dutta GC
    Appl Microbiol; 1974 Apr; 27(4):634-9. PubMed ID: 4207760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemistry of vibrio cholerae virulence. II. Skin permeability factor-cholera enterotoxin production in a chemically defined medium.
    Callahan LT; Ryder RC; Richardson SH
    Infect Immun; 1971 Nov; 4(5):611-8. PubMed ID: 5170548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of infant mice against cholera by antibodies to three antigens of Vibrio cholerae.
    Neoh SH; Rowley D
    J Infect Dis; 1972 Jul; 126(1):41-7. PubMed ID: 5038023
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunity and paralysis in mice. Serological and biological properties of two distinct antibodies to type III pneumococcal polysaccharide.
    Kearney R; Halliday WJ
    Immunology; 1970 Oct; 19(4):551-60. PubMed ID: 4394462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sensitivity of smooth and rough gram-negative bacteria to the immune bactericidal reaction.
    Muschel LH; Larsen LJ
    Proc Soc Exp Biol Med; 1970 Jan; 133(1):345-8. PubMed ID: 4904564
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunity against experimental cholera.
    Finkelstein RA; Atthasampunna P
    Proc Soc Exp Biol Med; 1967 Jun; 125(2):465-9. PubMed ID: 4961490
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of cellular structures of cholera and non-cholera vibrios in the development of non-specific resistance].
    Zykin LF; Petrova LS
    Antibiotiki; 1970 Jun; 15(6):537-40. PubMed ID: 5458636
    [No Abstract]   [Full Text] [Related]  

  • 14. Structural studies of products of antigen-antibody-complement interaction.
    Chan PC; Cebra JJ
    Immunochemistry; 1968 Jan; 5(1):1-8. PubMed ID: 4171678
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on Culex pipiens molestus in Israel. 3. Immune reactions in laboratory animals to extracts from the mosquito.
    Gold D; Lengy J
    Int Arch Allergy Appl Immunol; 1968; 34(6):571-9. PubMed ID: 4396198
    [No Abstract]   [Full Text] [Related]  

  • 16. Vibriocidal test and its parameters.
    Ganguly R; Deb BC; Shrivastava DL
    Indian J Med Res; 1969 May; 57(5):815-22. PubMed ID: 5820430
    [No Abstract]   [Full Text] [Related]  

  • 17. A study on the role of complement in the immune inhibition of mycoplasmal growth.
    Sethi KK; Teschner M
    Z Immunitatsforsch Allerg Klin Immunol; 1969 Nov; 138(5):458-74. PubMed ID: 4244398
    [No Abstract]   [Full Text] [Related]  

  • 18. Significance of vibriocidal antibodies with regard to immunity to cholera.
    Gangarosa EJ; DeWitt WE; Feeley JC; Adams MR
    J Infect Dis; 1970 May; 121():Suppl 121:36+. PubMed ID: 4912071
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative serological studies with homologous and heterologous antilysosomal serums].
    Wiedermann G; Denk H
    Z Immunitatsforsch Allerg Klin Immunol; 1970 Jul; 140(1):64-81. PubMed ID: 4247746
    [No Abstract]   [Full Text] [Related]  

  • 20. Quantitation of vibriocidal antibodies using agar plague techniques.
    Holmgren J; Svennerholm AM; Ouchterlony O
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1971; 79(5):708-14. PubMed ID: 5001359
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.